Two patients with severe vision loss regained their ability to read after surgeons implanted a microscopic patch of laboratory-grown eye cells beneath their retinas. Working in collaboration with University College London, surgeons at Moorfields Eye Hospital derived a specialized layer of retinal pigment epithelium cells, which nourish and support the eye's light-sensing photoreceptors, from human embryonic stem cells onto a thin synthetic scaffold.
During a surgical procedure lasting one to two hours, clinicians inserted this engineered patch directly underneath the retina of two patients, a woman in her 60s and a man in his 80s, both of whom had suffered sudden, severe sight loss due to wet age-related macular degeneration (AMD). Twelve months after receiving the implant, both individuals progressed from being completely unable to read even with corrective lenses to reading between 60 and 80 words per minute using standard reading glasses.
Published in Nature Biotechnology, this milestone addresses a major gap in ophthalmic care. Age-related macular degeneration is the primary cause of blindness among older adults, destroying the sharp central vision required to read, drive, and recognize faces. While standard ocular injections for wet AMD can slow down ongoing tissue deterioration, they cannot regenerate cells that have already died, which is precisely what this bioengineered patch was designed to replace.
Developed through the London Project to Cure Blindness, the initiative aims to scale this cellular therapy into an accessible, off-the-shelf treatment. The trial demonstrated for the first time that engineered tissue can restore a complex visual skill like reading, establishing a foundational blueprint for future stem cell therapies targeting retinal disease.
[da Cruz, L., Fynes, K., Georgiadis, O., Kerby, J., Luo, Y. H., Ahmado, A., Vernon, A., Daniels, J. T., Nommiste, B., Hasan, S. M., Gooljar, S. B., Carr, A.-J. F., Vugler, A., Ramsden, C. M., Bictash, M., Fenster, M., Steer, J., Harbinson, T., Wilbrey, A., Tufail, A., Feng, G., Whitlock, M., Robson, A. G., Holder, G. E., Sagoo, M. S., Loudon, P. T., Whiting, P., & Coffey, P. J. (2018). Phase 1 clinical study of an embryonic stem cell–derived retinal pigment epithelium patch in age-related macular degeneration. Nature Biotechnology, 36(4), 328–337. DOI: 10.1038/nbt.4114]